PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'University of Kentucky, Lexington, KY, USA.\', \'The University of Kansas Health System, Kansas City, KS, USA.\', \'ProMedica Toledo Hospital, Toledo, OH, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1177/10600280211036151
?:doi
?:hasPublicationType
?:journal
  • The Annals of pharmacotherapy
is ?:pmid of
?:pmid
?:pmid
  • 34323121
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Evaluation of Bivalirudin as the Primary Anticoagulant in Patients Receiving Extracorporeal Membrane Oxygenation for SARS-CoV-2-Associated Acute Respiratory Failure.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all